The anti-infective agents market is growing steadily, driven by the persistent burden of infectious diseases, rising antimicrobial resistance (AMR), and continuous demand for effective treatments against bacteria, viruses, and fungi. According to Business Market Insights, the market was valued at USD 145.85 billion in 2025 and is expected to reach USD 178.96 billion by 2033, registering a CAGR...